Skip to main content
Top
Published in: BMC Public Health 1/2013

Open Access 01-12-2013 | Research article

Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation

Authors: Johan Engdahl, Anders Holmén, Mårten Rosenqvist, Ulf Strömberg

Published in: BMC Public Health | Issue 1/2013

Login to get access

Abstract

Background

In a screening study for silent atrial fibrillation (AF), which is a frequent source of cardiac emboli with ischemic stroke, the proportion of non-participants was considerable and their clinical profile differed from the participants’ profile. We intended to geo-map the target population and non-participation in an attempt to understand factors related to screening uptake and, thereby, obtain useful information needed to intervene for improved uptake.

Method

In the municipality of Halmstad, Sweden, all residents born in 1934–1935 were invited to the screening study during April 2010 to February 2012. The total study group included 848 participants and 367 non-participants from 12 parishes. Geo-maps displaying participation, along with target-population-based geo-maps displaying proportion of immigrants and ischemic stroke incidence, were used.

Results

Smoothed non-participation ratios (SmNPR) varied from 0.81 to 1.24 across different parishes (SmNRP = 1 corresponds to the expected participation based on the total study group). Among high risk individuals, the geographical variation was more pronounced (SmNPR range 0.75–1.51). Two parishes with higher share of immigrants and elevated population-based ischemic stroke incidence showed markedly lower participation, particularly among high-risk individuals.

Conclusion

AF screening uptake varied evidently between parishes, particularly among high-risk individuals. Geo-mapping of target population and non-participation yielded useful information needed to intervene for improved screening uptake.
Appendix
Available only for authorised users
Literature
1.
go back to reference Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991, 22 (8): 983-988. 10.1161/01.STR.22.8.983.CrossRefPubMed Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991, 22 (8): 983-988. 10.1161/01.STR.22.8.983.CrossRefPubMed
2.
go back to reference Stewart S, Hart CL, Hole DJ, McMurray JJ: A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002, 113 (5): 359-364. 10.1016/S0002-9343(02)01236-6.CrossRefPubMed Stewart S, Hart CL, Hole DJ, McMurray JJ: A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am J Med. 2002, 113 (5): 359-364. 10.1016/S0002-9343(02)01236-6.CrossRefPubMed
3.
go back to reference Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, Krapf L, Lewalter T, Merioua I, Murin J, et al: Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 2011, 98 (3): 195-201.CrossRefPubMed Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, Krapf L, Lewalter T, Merioua I, Murin J, et al: Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry. Heart. 2011, 98 (3): 195-201.CrossRefPubMed
4.
go back to reference Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, Veltkamp R: Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis. 2011, 32 (3): 276-282.PubMed Rizos T, Wagner A, Jenetzky E, Ringleb PA, Becker R, Hacke W, Veltkamp R: Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis. 2011, 32 (3): 276-282.PubMed
5.
go back to reference Tagawa M, Takeuchi S, Chinushi M, Saeki M, Taniguchi Y, Nakamura Y, Ohno H, Kitazawa K, Aizawa Y: Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism. Pacing Clin Electrophysiol. 2007, 30 (9): 1121-1128. 10.1111/j.1540-8159.2007.00823.x.CrossRefPubMed Tagawa M, Takeuchi S, Chinushi M, Saeki M, Taniguchi Y, Nakamura Y, Ohno H, Kitazawa K, Aizawa Y: Evaluating patients with acute ischemic stroke with special reference to newly developed atrial fibrillation in cerebral embolism. Pacing Clin Electrophysiol. 2007, 30 (9): 1121-1128. 10.1111/j.1540-8159.2007.00823.x.CrossRefPubMed
6.
go back to reference Elijovich L, Josephson SA, Fung GL, Smith WS: Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis. 2009, 18 (3): 185-189. 10.1016/j.jstrokecerebrovasdis.2008.09.005.CrossRefPubMed Elijovich L, Josephson SA, Fung GL, Smith WS: Intermittent atrial fibrillation may account for a large proportion of otherwise cryptogenic stroke: a study of 30-day cardiac event monitors. J Stroke Cerebrovasc Dis. 2009, 18 (3): 185-189. 10.1016/j.jstrokecerebrovasdis.2008.09.005.CrossRefPubMed
7.
go back to reference Stahrenberg R, Weber-Kruger M, Seegers J, Edelmann F, Lahno R, Haase B, Mende M, Wohlfahrt J, Kermer P, Vollmann D, et al: Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010, 41 (12): 2884-2888. 10.1161/STROKEAHA.110.591958.CrossRefPubMed Stahrenberg R, Weber-Kruger M, Seegers J, Edelmann F, Lahno R, Haase B, Mende M, Wohlfahrt J, Kermer P, Vollmann D, et al: Enhanced detection of paroxysmal atrial fibrillation by early and prolonged continuous holter monitoring in patients with cerebral ischemia presenting in sinus rhythm. Stroke. 2010, 41 (12): 2884-2888. 10.1161/STROKEAHA.110.591958.CrossRefPubMed
8.
go back to reference Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, et al: Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled ‘research perspectives in atrial fibrillation’. Europace. 2009, 11 (7): 860-885. 10.1093/europace/eup124.CrossRefPubMed Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, et al: Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled ‘research perspectives in atrial fibrillation’. Europace. 2009, 11 (7): 860-885. 10.1093/europace/eup124.CrossRefPubMed
9.
go back to reference Ericson L, Bergfeldt L, Bjorholt I: Atrial fibrillation: the cost of illness in Sweden. Eur J Health Econ. 2011, 12 (5): 479-487. 10.1007/s10198-010-0261-3.CrossRefPubMed Ericson L, Bergfeldt L, Bjorholt I: Atrial fibrillation: the cost of illness in Sweden. Eur J Health Econ. 2011, 12 (5): 479-487. 10.1007/s10198-010-0261-3.CrossRefPubMed
10.
go back to reference Indredavik B, Rohweder G, Lydersen S: Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med. 2005, 258 (2): 133-144. 10.1111/j.1365-2796.2005.01512.x.CrossRefPubMed Indredavik B, Rohweder G, Lydersen S: Frequency and effect of optimal anticoagulation before onset of ischaemic stroke in patients with known atrial fibrillation. J Intern Med. 2005, 258 (2): 133-144. 10.1111/j.1365-2796.2005.01512.x.CrossRefPubMed
11.
go back to reference Leckey R, Aguilar EG, Phillips SJ: Atrial fibrillation and the use of warfarin in patients admitted to an acute stroke unit. Can J Cardiol. 2000, 16 (4): 481-485.PubMed Leckey R, Aguilar EG, Phillips SJ: Atrial fibrillation and the use of warfarin in patients admitted to an acute stroke unit. Can J Cardiol. 2000, 16 (4): 481-485.PubMed
12.
go back to reference Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, et al: Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012, 366 (2): 120-129. 10.1056/NEJMoa1105575.CrossRefPubMed Healey JS, Connolly SJ, Gold MR, Israel CW, Van Gelder IC, Capucci A, Lau CP, Fain E, Yang S, Bailleul C, et al: Subclinical atrial fibrillation and the risk of stroke. N Engl J Med. 2012, 366 (2): 120-129. 10.1056/NEJMoa1105575.CrossRefPubMed
13.
go back to reference Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, et al: Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004, 25 (16): 1385-1394. 10.1016/j.ehj.2004.04.015.CrossRefPubMed Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, et al: Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial. Eur Heart J. 2004, 25 (16): 1385-1394. 10.1016/j.ehj.2004.04.015.CrossRefPubMed
14.
go back to reference Engdahl J, Andersson L, Mirskaya M, Rosenqvist M: Stepwise screening of atrial fibrillation in a 75-year old population - implications for stroke prevention. Circulation. 2013, 127: 930-937. 10.1161/CIRCULATIONAHA.112.126656.CrossRefPubMed Engdahl J, Andersson L, Mirskaya M, Rosenqvist M: Stepwise screening of atrial fibrillation in a 75-year old population - implications for stroke prevention. Circulation. 2013, 127: 930-937. 10.1161/CIRCULATIONAHA.112.126656.CrossRefPubMed
15.
go back to reference Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G: A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005, 9 (40): iii-iv, ix-x, 1–74-CrossRefPubMed Hobbs FD, Fitzmaurice DA, Mant J, Murray E, Jowett S, Bryan S, Raftery J, Davies M, Lip G: A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study. Health Technol Assess. 2005, 9 (40): iii-iv, ix-x, 1–74-CrossRefPubMed
16.
go back to reference Tveit A, Abdelnoor M, Enger S, Smith P: Atrial fibrillation and antithrombotic therapy in a 75-year-old population. Cardiology. 2008, 109 (4): 258-262. 10.1159/000107789.CrossRefPubMed Tveit A, Abdelnoor M, Enger S, Smith P: Atrial fibrillation and antithrombotic therapy in a 75-year-old population. Cardiology. 2008, 109 (4): 258-262. 10.1159/000107789.CrossRefPubMed
17.
go back to reference Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001, 285 (22): 2864-2870. 10.1001/jama.285.22.2864.CrossRefPubMed Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ: Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001, 285 (22): 2864-2870. 10.1001/jama.285.22.2864.CrossRefPubMed
19.
go back to reference Beale L, Abellan JJ, Hodgson S, Jarup L: Methodologic issues and approaches to spatial epidemiology. Environ Health Perspect. 2008, 116 (8): 1105-1110. 10.1289/ehp.10816.CrossRefPubMedPubMedCentral Beale L, Abellan JJ, Hodgson S, Jarup L: Methodologic issues and approaches to spatial epidemiology. Environ Health Perspect. 2008, 116 (8): 1105-1110. 10.1289/ehp.10816.CrossRefPubMedPubMedCentral
20.
go back to reference Clayton D, Kaldor J: Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics. 1987, 43 (3): 671-681. 10.2307/2532003.CrossRefPubMed Clayton D, Kaldor J: Empirical Bayes estimates of age-standardized relative risks for use in disease mapping. Biometrics. 1987, 43 (3): 671-681. 10.2307/2532003.CrossRefPubMed
21.
go back to reference Richardson S, Thomson A, Best N, Elliott P: Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect. 2004, 112 (9): 1016-1025. 10.1289/ehp.6740.CrossRefPubMedPubMedCentral Richardson S, Thomson A, Best N, Elliott P: Interpreting posterior relative risk estimates in disease-mapping studies. Environ Health Perspect. 2004, 112 (9): 1016-1025. 10.1289/ehp.6740.CrossRefPubMedPubMedCentral
22.
go back to reference Gimeno García AZ: Factors influencing colorectal cancer screening participation. Gastroenterology Res Pract. 2012, 2012: 483417- Gimeno García AZ: Factors influencing colorectal cancer screening participation. Gastroenterology Res Pract. 2012, 2012: 483417-
23.
go back to reference Le Breton J, Journy N, Attali C, Le Corvoisier P, Brixi Z, Bastuji-Garin S, Chevreul K: Improving participation in colorectal cancer screening: targets for action. Prev Med. 2012, 55 (5): 488-492. 10.1016/j.ypmed.2012.08.004.CrossRefPubMed Le Breton J, Journy N, Attali C, Le Corvoisier P, Brixi Z, Bastuji-Garin S, Chevreul K: Improving participation in colorectal cancer screening: targets for action. Prev Med. 2012, 55 (5): 488-492. 10.1016/j.ypmed.2012.08.004.CrossRefPubMed
24.
go back to reference Wee LE, Koh GC, Chin RT, Yeo WX, Seow B, Chua D: Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention. Prev Med. 2012, 55 (1): 61-67. 10.1016/j.ypmed.2012.04.011.CrossRefPubMed Wee LE, Koh GC, Chin RT, Yeo WX, Seow B, Chua D: Socioeconomic factors affecting colorectal, breast and cervical cancer screening in an Asian urban low-income setting at baseline and post-intervention. Prev Med. 2012, 55 (1): 61-67. 10.1016/j.ypmed.2012.04.011.CrossRefPubMed
25.
go back to reference Wanhainen A, Svensjo S, Tillberg M, Mani K, Bjorck M: Abdominal aortic aneurysm screening in Uppsala. Good experiences from the first four years–the rest of Sweden on its way. Lakartidningen. 2010, 107 (38): 2232-2236.PubMed Wanhainen A, Svensjo S, Tillberg M, Mani K, Bjorck M: Abdominal aortic aneurysm screening in Uppsala. Good experiences from the first four years–the rest of Sweden on its way. Lakartidningen. 2010, 107 (38): 2232-2236.PubMed
27.
go back to reference Soljak M, Samarasundera E, Indulkar T, Walford H, Majeed A: Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysis. BMC Cardiovasc Disord. 2011, 11: 12-10.1186/1471-2261-11-12.CrossRefPubMedPubMedCentral Soljak M, Samarasundera E, Indulkar T, Walford H, Majeed A: Variations in cardiovascular disease under-diagnosis in England: national cross-sectional spatial analysis. BMC Cardiovasc Disord. 2011, 11: 12-10.1186/1471-2261-11-12.CrossRefPubMedPubMedCentral
Metadata
Title
Uptake of atrial fibrillation screening aiming at stroke prevention: geo-mapping of target population and non-participation
Authors
Johan Engdahl
Anders Holmén
Mårten Rosenqvist
Ulf Strömberg
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2013
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/1471-2458-13-715

Other articles of this Issue 1/2013

BMC Public Health 1/2013 Go to the issue